|
Report Date : |
01.03.2013 |
IDENTIFICATION DETAILS
|
Name : |
M.P.I. PHARMACEUTICA GMBH |
|
|
|
|
Registered Office : |
Ballindamm 8, D 20095 Hamburg |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
13.09.1985 |
|
|
|
|
Com. Reg. No.: |
HRB
65217 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturer
of pharmaceutical preparations |
|
|
|
|
No. of Employees : |
23 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
germany - ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world in PPP terms
and Europe's largest - is a leading exporter of machinery, vehicles, chemicals,
and household equipment and benefits from a highly skilled labor force. Like
its Western European neighbors, Germany faces significant demographic
challenges to sustained long-term growth. Low fertility rates and declining net
immigration are increasing pressure on the country's social welfare system and
necessitate structural reforms. Reforms launched by the government of
Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address
chronically high unemployment and low average growth, contributed to strong
growth in 2006 and 2007 and falling unemployment. These advances, as well as a
government subsidized, reduced working hour scheme, help explain the relatively
modest increase in unemployment during the 2008-09 recession - the deepest
since World War II - and its decrease to 6.0% in 2011. GDP contracted 5.1% in
2009 but grew by 3.6% in 2010, and 2.7% in 2011. The recovery was attributable
primarily to rebounding manufacturing orders and exports - increasingly outside
the Euro Zone. Germany's central bank projects that GDP will grow 0.6% in 2012,
a reflection of the worsening euro-zone financial crisis and the financial
burden it places on Germany as well as falling demand for German exports.
Domestic demand is therefore becoming a more significant driver of Germany's
economic expansion. Stimulus and stabilization efforts initiated in 2008 and
2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased
Germany's budget deficit to 3.3% in 2010, but slower spending and higher tax
revenues reduce the deficit to 1.7% in 2011, below the EU's 3% limit. A
constitutional amendment approved in 2009 limits the federal government to
structural deficits of no more than 0.35% of GDP per annum as of 2016.
Following the March 2011 Fukushima nuclear disaster, Chancellor Angela Merkel
announced in May 2011 that eight of the country's 17 nuclear reactors would be
shut down immediately and the remaining plants would close by 2022. Germany
hopes to replace nuclear power with renewable energy. Before the shutdown of
the eight reactors, Germany relied on nuclear power for 23% of its energy and
46% of its base-load electrical production.
|
Source : CIA |
M.P.I.
Pharmaceutica GmbH
Ballindamm 8
D 20095 Hamburg
Telephone: 040/303724-0
Telefax: 040/303724-20
Homepage: www.mpi-pharma.com
E-mail: info@mpi-pharma.de
Company
Status: active
DE118671386
Business
relations are permissible.
LEGAL FORM Private limited company
Date of foundation: 13.09.1985
Shareholders'
agreement: 13.09.1985
Registered on: 26.08.1997
Commercial Register: Local
court 20355 Hamburg
under: HRB 65217
Share capital:
EUR 130,000.00
Franz Wilhelm Gerhardy
Dörpfeldstieg 1
D 22609 Hamburg
born: 12.05.1941
Share: EUR 130,000.00
Franz Wilhelm Gerhardy
Dörpfeldstieg 1
D 22609 Hamburg
having sole power of representation
born: 12.05.1941
Profession: Businessman
Marital status: married
Christoph Frese
D 20095 Hamburg
authorized to jointly represent the company
born: 03.03.1938
Profession: Businessman
Marital status: unknown
Further
functions/participations of Franz Wilhelm Gerhardy
(Manager)
Shareholder:
ALPHACHEM Im- +
Exportgesellschaft mbH
Ballindamm 8
D 20095 Hamburg
Legal form: Private
limited company
Share capital: EUR 30,677.51
Share: EUR 30,677.51
Registered
on: 22.11.1984
Reg. data: 20355 Hamburg, HRB 33448
Manager:
IMEDIKA Chemie GmbH
Ballindamm 8
D 20095 Hamburg
Legal form: Private
limited company
Share capital: EUR 25,000.00
Registered
on: 20.12.2002
Reg. data: 20355 Hamburg, HRB 85890
Manager:
ALPHACHEM Im- +
Exportgesellschaft mbH
Ballindamm 8
D 20095 Hamburg
Legal form: Private
limited company
Share capital: EUR 30,677.51
Registered
on: 22.11.1984
Reg. data: 20355 Hamburg, HRB 33448
07.09.1998 - 02.10.1998 M.P.I. Pharmaceutica GmbH
Spohrstr. 2
D 22083 Hamburg
Private limited
company
Sectors
21200 Manufacture of pharmaceutical preparations
46461 Wholesale of pharmaceutical goods
Payment experience: within
agreed terms
Negative information: We
have no negative information at hand.
Balance sheet year: 2010
Type of ownership: Tenant
Address Ballindamm
8
D 20095 Hamburg
Land register documents were not available.
DEUTSCHE BANK,
HAMBURG
Sort. code: 20070000, Account no.: 6426605, BIC: DEUTDEHHXXX
HAMBURGER SPARKASSE,
HAMBURG
Sort. code: 20050550, Account no.: 1280117357, BIC: HASPDEHHXXX
UNICREDIT BANK - HYPOVEREINSBANK,
HAMBURG
Sort. code: 20030000, Account no.: 1160126, BIC: HYVEDEMM300
Gross profit or
loss:2011 EUR 5,000,000.00
2012 EUR 5,000,000.00
further business figures:
Equipment: EUR 28,076.00
Ac/ts receivable: EUR 6,317,628.00
Liabilities: EUR 4,203,539.00
Employees:
23
Balance sheet ratios
01.01.2010 - 31.12.2010
Equity ratio [%]: 42.65
Liquidity ratio: 1.58
Return on total capital
[%]: 5.56
Balance sheet ratios
01.01.2009 - 31.12.2009
Equity ratio [%]: 45.81
Liquidity ratio: 1.87
Return on total capital
[%]: 9.77
Balance sheet ratios
01.01.2008 - 31.12.2008
Equity ratio [%]: 27.55
Liquidity ratio: 1.21
Return on total capital
[%]: 4.62
Balance sheet ratios
01.01.2007 - 31.12.2007
Equity ratio [%]: 19.14
Liquidity ratio: 1.12
Return on total capital
[%]: 3.00
Equity ratio
The equity ratio indicates the portion of the equity as compared
to the total capital. The higher the equity ratio, the better the
economic stability (solvency) and thus the financial autonomy of
a company.
Liquidity ratio
The liquidity ratio shows the proportion between adjusted
receivables and net liabilities. The higher the ratio, the lower
the company's financial dependancy from external creditors.
Return on total
capital
The return on total capital shows the efficiency and return on
the total capital employed in the company. The higher the return
on total capital, the more economically does the company work
with the invested capital.
Type of balance
sheet: Company balance sheet
Financial year: 01.01.2010 - 31.12.2010
ASSETS EUR 7,309,669.01
Fixed assets EUR 28,076.00
Tangible assets EUR 28,076.00
Other tangible assets /
fixtures and
fittings EUR 28,076.00
Current assets EUR 7,275,961.88
Stocks EUR 936,003.36
Accounts receivable EUR 6,317,628.39
Trade debtors EUR 6,180,373.85
Other debtors and
assets EUR 137,254.54
Liquid means EUR 22,330.13
Remaining other
assets EUR 5,631.13
Accruals (assets) EUR 5,631.13
LIABILITIES EUR 7,309,669.01
Shareholders' equity EUR 2,932,289.35
Capital EUR 128,334.26
Subscribed capital
(share capital) EUR 128,334.26
Balance sheet profit/loss
(+/-) EUR 2,803,955.09
Balance sheet profit /
loss EUR 2,803,955.09
Provisions EUR 173,840.58
Liabilities EUR
4,203,539.08
Financial debts EUR 2,233,285.41
Liabilities due to
banks EUR 2,233,285.41
Other liabilities EUR 1,970,253.67
Trade creditors (for IAS
incl. bills
of exchange) EUR 1,745,409.76
Unspecified other
liabilities EUR 224,843.91
PROFIT AND LOSS ACCOUNT
(cost-summary method) according to Comm.
Code (HGB)
Gross result (+/-) EUR 4,977,691.60
Staff expenses EUR 609,000.39
Wages and salaries EUR 526,311.87
Social security
contributions and
expenses for pension
plans and
benefits EUR 82,688.52
Total depreciation EUR 19,117.41
Depreciation on tangible
/ intangible
asssets (incl. start-up
and exp. of
bus. EUR 19,117.41
Other operating
expenses EUR 3,670,142.83
Operating result from
continuing
operations EUR 679,430.97
Interest result (+/-) EUR -86,015.11
Interest and similar
income EUR 477.40
Interest and similar
expenses EUR 86,492.51
Financial result
(+/-) EUR -86,015.11
Result from ordinary
operations (+/-) EUR 593,415.86
Extraordinary
expenses EUR 29,909.00
Extraordinary result
(+/-) EUR -29,909.00
Income tax / refund of
income tax (+/-)EUR -186,262.12
Other taxes / refund of
taxes EUR -617.00
Tax (+/-) EUR -186,879.12
Annual surplus / annual
deficit EUR 376,627.74
Type of balance
sheet: Company balance sheet
Financial year: 01.01.2009 - 31.12.2009
ASSETS EUR 6,124,289.88
Fixed assets EUR 212,438.00
Tangible assets EUR 42,438.00
Other tangible assets /
fixtures and
fittings EUR 42,438.00
Financial assets EUR 170,000.00
Other / unspecified
financial assets EUR
170,000.00
Current assets EUR 5,909,733.20
Stocks EUR 686,866.19
Accounts receivable EUR 4,908,915.03
Other debtors and
assets EUR 4,908,915.03
Liquid means EUR 313,951.98
Remaining other
assets EUR 2,118.68
Accruals (assets) EUR 2,118.68
LIABILITIES EUR 6,124,289.88
Shareholders' equity EUR
2,555,661.61
Capital EUR 128,334.26
Subscribed capital
(share capital) EUR 128,334.26
Balance sheet profit/loss
(+/-) EUR 2,427,327.35
Balance sheet profit / loss EUR 2,427,327.35
Provisions EUR 383,131.82
Liabilities EUR 3,185,496.45
Financial debts EUR 1,525,877.73
Liabilities due to
banks EUR 1,525,877.73
Other liabilities EUR 1,659,618.72
Unspecified other
liabilities EUR 1,659,618.72
PROFIT AND LOSS ACCOUNT
(cost-summary method) according to Comm.
Code (HGB)
Gross result (+/-) EUR 4,845,696.55
Staff expenses EUR 653,272.89
Wages and salaries EUR 565,646.14
Social security
contributions and
expenses for pension
plans and
benefits EUR 87,626.75
Total depreciation EUR 12,377.43
Depreciation on tangible
/ intangible
asssets (incl. start-up
and exp. of
bus. EUR 12,377.43
Other operating
expenses EUR 3,176,812.75
Operating result from
continuing
operations EUR 1,003,233.48
Interest result (+/-) EUR
-111,012.01
Interest and similar
income EUR 4,890.42
Interest and similar
expenses EUR 115,902.43
Financial result
(+/-) EUR -111,012.01
Result from ordinary operations
(+/-) EUR 892,221.47
Income tax / refund of
income tax (+/-)EUR -293,183.88
Other taxes / refund of
taxes EUR -465.00
Tax (+/-) EUR -293,648.88
Annual surplus / annual
deficit EUR 598,572.59
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.77 |
|
UK Pound |
1 |
Rs.81.57 |
|
Euro |
1 |
Rs.70.68 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.